Danimer Scientific, Inc. (DNMR) Financials
DNMR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 721.0 million | 416.7 million |
2023-06-30 | 744.3 million | 414.0 million |
2023-03-31 | 778.6 million | 423.0 million |
2022-12-31 | 712.3 million | 334.7 million |
DNMR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.9 million | 14.3 million |
2023-06-30 | -21.9 million | 13.9 million |
2023-03-31 | -22.3 million | 14.1 million |
2022-12-31 | -35.1 million | 14.6 million |
DNMR Net Income
No data available :(
DNMR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 77.4 million | - | 25.3 million |
2023-06-30 | 90.8 million | - | 25.3 million |
2023-03-31 | 102.0 million | - | 25.4 million |
2022-12-31 | 62.8 million | - | 25.5 million |
DNMR Shares Outstanding
DNMR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 2.7 million | 6.9 million | 16.6 million | - |
2023-06-30 | 6.6 million | 7.7 million | 16.8 million | - |
2023-03-31 | 16.4 million | 7.1 million | 18.7 million | - |
2022-12-31 | 30.9 million | 7.5 million | 19.0 million | - |
DNMR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 10.9 million | 18.7 million |
2023-06-30 | 12.9 million | 19.4 million |
2023-03-31 | 11.9 million | 18.2 million |
2022-12-31 | 15.3 million | 18.0 million |
DNMR
Price: $0.81
52 week price:
Earnings Per Share: -1.42 USD
P/E Ratio: -0.46
Exchange: NYQ
Sector: Basic Materials
Industry: Specialty Chemicals
Volume: 1.3 million
Market Capitalization: 120.0 million